April 25, 2024 02:43 PM EDT
Pharma
Law

GSK ac­cus­es Pfiz­er and BioN­Tech of mR­NA patent in­fringe­ment

Nicole DeFeudis

Editor

GSK says it is owed a por­tion of Pfiz­er and BioN­Tech’s Covid-19 vac­cine sales in the lat­est patent suit filed against the Comir­naty part­ners. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CDER Di­rec­tor Pa­trizia Cavaz­zoni to step down ahead of Trump pres­i­den­cy

Ex­clu­sive: Mod­er­na's for­mer top sci­en­tist has a new start­up us­ing AI to im­prove mR­NA ther­a­pies

In­tel­lia to cut work­force by 27%, plans com­mer­cial­iza­tion of first CRISPR ther­a­py in 2027

Four biotechs emerge with $800M and in-li­censed as­sets on Fri­day

Lil­ly ven­tures in­to pul­monary fi­bro­sis with start­up Me­di­ar

John Maraganore turns to ex-Al­ny­lam col­league to lead his lat­est RNAi bet; Amy­lyx names com­mer­cial chief

A service from the Financial Times